+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

Non-Opioid Pain Patch Market Report 2025 - Product Thumbnail Image

Non-Opioid Pain Patch Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pain Management Drugs Market Report 2025 - Product Thumbnail Image

Pain Management Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Oxycodone Drugs Global Market Report 2024 - Product Thumbnail Image

Oxycodone Drugs Global Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
From
Pain Management Devices - Global Strategic Business Report - Product Thumbnail Image

Pain Management Devices - Global Strategic Business Report

  • Report
  • February 2025
  • 118 Pages
  • Global
From
From
From
From
Pain Management Devices Market 2024-2028 - Product Thumbnail Image

Pain Management Devices Market 2024-2028

  • Report
  • July 2024
  • 172 Pages
  • Global
From
Postoperative Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Postoperative Pain - Pipeline Insight, 2024

  • Drug Pipelines
  • June 2024
  • 180 Pages
  • Global
From
From
From
From
From
Diabetic Neuropathic Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more